🇺🇸 Castle Biosciences, Inc.
Forum topic · CSTL · Company page: financials, ownership and filings
Join the discussion on Castle Biosciences, Inc.
Loading…
Results announced on 5 November 2026
Castle Biosciences, Inc. announced results on 5 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $103 million (up 24% from a year earlier) and a net loss of $4 million.
Insider trading in October 2026
Directors and officers of Castle Biosciences, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 3 insiders sold shares worth about $1,586,416 in 12 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 186 funds hold $221 million
186 mutual funds in 1 country hold shares of Castle Biosciences, Inc. worth $221 million, about 29.0% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 90 funds added shares and 59 sold; on balance they sold $26 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.